Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marco Ophthalmic is a leading provider of diagnostic ophthalmic equipment and vision care technology. Founded in 1967 and headquartered in Jacksonville, Florida, the company specializes in automated refraction systems, digital slit lamps, and retinal imaging technologies. Marco is widely recognized for its long-term partnership with Nidek, serving as a primary distributor of advanced Japanese diagnostic instrumentation in North America. Their product portfolio, including the TRS Total Refraction System and OPD-Scan, is designed to improve clinical efficiency and diagnostic accuracy for eye care professionals. In 2019, the company joined the Advancing Eyecare alliance, a group of leading ophthalmic instrument providers backed by private equity. Today, Marco continues to support optometrists and ophthalmologists with high-end diagnostic solutions and comprehensive technical service.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marco Ophthalmic.